World Congress on Precision Biotherapeutics - 2026
The World Congress on Precision Biotherapeutics (WCPB) is the premier global scientific forum dedicated to bridging antibody-drug conjugates (ADCs), RNA therapeutics, gene & cell therapies, radiopharmaceuticals, and precision medicine. gfsdasfd
To become the world's leading scientific congress dedicated to advancing precision biotherapeutics by fostering innovation, interdisciplinary collaboration, and knowledge exchange that transform the future of targeted therapies and improve global health outcomes. sadfasdf
The World Congress on Precision Biotherapeutics (WCPB) is committed to bringing together scientists, clinicians, healthcare professionals, industry leaders, regulators, policymakers, and innovators from around the world to share cutting-edge research, promote scientific excellence, facilitate multidisciplinary collaboration, and accelerate the translation of breakthrough discoveries into safe, effective, and accessible precision biotherapeutics.
Through high-quality scientific sessions, educational programs, industry engagement, and global networking opportunities, WCPB strives to shape the future of precision medicine and next-generation biotherapeutics.
The World Congress on Precision Biotherapeutics (WCPB) aims to serve as a premier global scientific platform that brings together researchers, clinicians, industry leaders, regulators, policymakers, and innovators to advance the discovery, development, clinical translation, and commercialization of precision biotherapeutics. The congress is dedicated to fostering interdisciplinary collaboration, accelerating scientific innovation, and improving patient outcomes through next-generation targeted therapies.
Long-term strategic goals driving scientific excellence and therapeutic advancement at WCPB
Showcase the latest discoveries and emerging trends in antibody-drug conjugates (ADCs), RNA therapeutics, gene and cell therapies, radiopharmaceuticals, targeted protein degraders, and other precision bitherapeutic technologies.
Bridge the gap between basic research and clinical practice by highlighting translational science, biomarker-driven therapeutic strategies, and real-world clinical applications.
Foster partnerships among academic institutions, healthcare organizations, biotechnology companies, pharmaceutical industries, regulatory agencies, and patient advocacy groups to accelerate innovation.
Provide a platform for presenting novel technologies in drug discovery, molecular targeting, delivery systems, artificial intelligence, computational biology, and precision medicine.
Promote evidence-based approaches to precision therapeutics through discussions on clinical trials, companion diagnostics, personalized treatment strategies, and patient-centered care.
Explore global regulatory frameworks, quality systems, manufacturing innovations, commercialization strategies, and market access for advanced biotherapeutics.
Encourage the participation of students, postdoctoral researchers, early-career investigators, and young clinicians through mentoring, networking opportunities, awards, and scientific presentations.
Create opportunities for collaboration between academia and industry to accelerate technology transfer, product development, investment, and commercialization.
Deliver high-quality keynote lectures, scientific sessions, workshops, panel discussions, and hands-on learning experiences that support continuous professional development.
Establish WCPB as a long-term international forum that supports year-round collaboration, scientific communication, and dissemination of research through its official publication, the Journal of Precision Biotherapeutics (JPB).
The fundamental values that define our culture, ethics, and commitment to global healthcare
We uphold the highest standards of scientific rigor, integrity, innovation, and evidence-based research in all congress activities.
We encourage the discovery and development of transformative technologies that advance targeted therapies, molecular medicine, and precision healthcare.
We believe that multidisciplinary and international partnerships among academia, healthcare, industry, regulatory authorities, and patient organizations are essential for accelerating scientific progress.
We promote ethical conduct, transparency, fairness, and accountability in research, clinical practice, publication, and professional interactions.
We are committed to improving patient outcomes by supporting research that enables safer, more effective, and personalized therapeutic solutions.
We provide an inclusive platform for lifelong learning, scientific discussion, mentorship, and professional development across all career stages.
We foster a welcoming environment that values diverse perspectives, promotes equal opportunities, and encourages participation from scientists and healthcare professionals worldwide.
We support responsible scientific innovation, environmentally conscious event management, and sustainable partnerships that contribute to long-term healthcare advancement.
We strengthen international cooperation to address emerging healthcare challenges and accelerate the worldwide adoption of innovative precision biotherapeutics.